One-year results of visual response following intravitreal novel anti-VEGF injection for diabetic macular edema in a Latino population
Abstract Background Diabetic macular edema (DME) is a leading cause of vision impairment. This study evaluated the effects of multiple anti-VEGF intravitreal injections, including a novel anti-VEGF PRO-169, on best-corrected visual acuity (BCVA) and central macular thickness (CMT) in Latino patients...
Saved in:
| Main Authors: | Guillermo Salcedo-Villanueva, Gisela Garcia-Sánchez, Claudia Palacio-Pastrana, Gerardo Gascón-Guzmán, Aureliano Moreno-Andrade, Oscar Olvera-Montaño, Patricia Muñoz-Villegas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | International Journal of Retina and Vitreous |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40942-025-00719-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema
by: Fatima Shafqat Khan, et al.
Published: (2023-12-01) -
A machine learning model for predicting anatomical response to Anti-VEGF therapy in diabetic macular edema
by: Wenrui Lu, et al.
Published: (2025-05-01) -
Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema—A Swiss Cohort Study
by: Ferhat Turgut, et al.
Published: (2024-09-01) -
Сlinical, functional and morphological results of diabetic macular edema antiangiogenic treatment in patients with diabetes mellitus type two
by: L. K. Moshetova, et al.
Published: (2014-07-01) -
Modern view on the treatment of diabetic macular edema
by: A.V. Shelankova, et al.
Published: (2022-07-01)